NCT03644810 is a NA clinical trial of PPT measurement in Catastrophizing Pain, sponsored by Aalborg University.

Who is sponsoring NCT03644810?

NCT03644810 is sponsored by Aalborg University.

What drugs are being tested in NCT03644810?

Interventions in NCT03644810: PPT measurement, Pain catastrophizing scale, Cold Pressor Test.

What condition does NCT03644810 study?

NCT03644810 studies Catastrophizing Pain, Pain, Somatic, Chronic Low Back Pain.

Is NCT03644810 still recruiting?

NCT03644810 is currently completed. Last updated 24 December 2018.

Last reviewed 2018-12-24 · How we verify

NCT03644810

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Association Between Conditioned Pain Modulation and Pain Catastrophizing in Chronic Low Back Pain

Completed NA Last updated 24 December 2018

What this trial tests

NA trial testing PPT measurement in Catastrophizing Pain in 44 participants. Completed in 8 November 2018.

Timeline

1 May 2017

Primary endpoint
1 September 2017

8 November 2018

Quick facts

Lead sponsor	Aalborg University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	44
Start date	1 May 2017
Primary completion	1 September 2017
Estimated completion	8 November 2018
Sites	1 location across Denmark

Drugs / interventions tested

PPT measurement
Pain catastrophizing scale
Cold Pressor Test

Conditions studied

Catastrophizing Pain — all drugs for Catastrophizing Pain →
Pain, Somatic — all drugs for Pain, Somatic →
Chronic Low Back Pain — all drugs for Chronic Low Back Pain →

Sponsor

Aalborg University

Who can join

Adults 18 to 60, any sex, with Catastrophizing Pain or Pain, Somatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the potential association between pain catastrophizing thoughts and the ability to dampen pain via endogenous descending inhibition. Half of the participants are persons with chronic low back pain and the other half are age and gender-matched controls

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Catastrophizing Pain

Currently open trials in the same condition.

NCT06813352 — Analysis of Facial Expressions for Pain Recognition in Fibromyalgia: Using Artificial Intelligence and Biomarkers · recruiting

Other Aalborg University trials

Trials by the same sponsor.

NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
NCT07395882 — A New Model to Induce Itch and Inflammation · NA · not yet recruiting
NCT07395869 — Off-set Analgesia Induced by Cold Temperature · NA · not yet recruiting
NCT07266103 — Mechanistic Study of Personalized rTMS in Chronic Pain · NA · not yet recruiting
NCT07373392 — Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals Wi · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03644810 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aalborg University
Last refreshed: 24 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03644810.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing